Mr. Damien McCallion:

For the following week, the team is working through the additional numbers from Pfizer that we are getting and we are also dealing now with a shortfall in AstraZeneca. When we complete that we will have a number for next week. Our aim, for next week, would be to increase the numbers that we are doing.